tetano
Editor, Senior Moderator
Emerg Infect Dis. 2020 Feb 17;26(2). doi: 10.3201/eid2502.191105. [Epub ahead of print] [h=1]Antigenic Variant of Highly Pathogenic Avian Influenza A(H7N9) Virus, China, 2019.[/h]
Jiang W, Hou G, Li J, Peng C, Wang S, Liu S, Zhuang Q, Yuan L, Yu X, Li Y, Wang J, Liu H.
[h=3]Abstract[/h] In China, influenza A(H7N9) virus appeared in 2013, then mutated into a highly pathogenic virus, causing outbreaks among poultry and cases in humans. Since September 2017, extensive use of the corresponding vaccine, H7-Re1, successfully reduced virus prevalence. However, in 2019, a novel antigenic variant emerged, posing considerable economic and public health threats.A.
[h=4]KEYWORDS:[/h] China; H7N9; HPAI; Influenza virus; antigenicity; highly pathogenic avian influenza; influenza; variant; viruses
PMID: 31855533 DOI: 10.3201/eid2502.191105
Free full text
Jiang W, Hou G, Li J, Peng C, Wang S, Liu S, Zhuang Q, Yuan L, Yu X, Li Y, Wang J, Liu H.
[h=3]Abstract[/h] In China, influenza A(H7N9) virus appeared in 2013, then mutated into a highly pathogenic virus, causing outbreaks among poultry and cases in humans. Since September 2017, extensive use of the corresponding vaccine, H7-Re1, successfully reduced virus prevalence. However, in 2019, a novel antigenic variant emerged, posing considerable economic and public health threats.A.
[h=4]KEYWORDS:[/h] China; H7N9; HPAI; Influenza virus; antigenicity; highly pathogenic avian influenza; influenza; variant; viruses
PMID: 31855533 DOI: 10.3201/eid2502.191105
Free full text